Rosa Ayala

3.2k total citations
92 papers, 940 citations indexed

About

Rosa Ayala is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Rosa Ayala has authored 92 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 32 papers in Molecular Biology and 32 papers in Genetics. Recurrent topics in Rosa Ayala's work include Acute Myeloid Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). Rosa Ayala is often cited by papers focused on Acute Myeloid Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). Rosa Ayala collaborates with scholars based in Spain, United States and Italy. Rosa Ayala's co-authors include Joaquín Martínez‐López, Florinda Gilsanz, Inmaculada Rapado, Miguel Gallardo, Ricardo Sánchez, Santiago Barrio, Enrique Moreno, José‐Ángel Hernández‐Rivas, Marı́a José Calasanz and José Cervera and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rosa Ayala

80 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Ayala Spain	19	425	358	239	207	116	92	940
Israel Bendit Brazil	17	423 1.0×	197 0.6×	296 1.2×	208 1.0×	163 1.4×	82	818
Zdeněk Adam Czechia	14	522 1.2×	482 1.3×	100 0.4×	298 1.4×	94 0.8×	156	929
Emma Das‐Gupta United Kingdom	18	725 1.7×	425 1.2×	180 0.8×	261 1.3×	35 0.3×	34	1.2k
Radovan Vrḫovac Croatia	15	243 0.6×	223 0.6×	330 1.4×	253 1.2×	65 0.6×	65	810
Marta Krejčí Czechia	17	832 2.0×	497 1.4×	190 0.8×	574 2.8×	88 0.8×	155	1.3k
Ana Balanzategui Spain	25	491 1.2×	440 1.2×	492 2.1×	459 2.2×	70 0.6×	70	1.5k
Claudia Baratè Italy	19	513 1.2×	225 0.6×	499 2.1×	190 0.9×	207 1.8×	56	1.0k
AnneMarie W. Block United States	20	926 2.2×	543 1.5×	408 1.7×	278 1.3×	45 0.4×	62	1.6k
Yeo‐Kyeoung Kim South Korea	20	675 1.6×	412 1.2×	253 1.1×	261 1.3×	58 0.5×	91	1.2k
Sabine Pomplun United Kingdom	15	603 1.4×	357 1.0×	274 1.1×	203 1.0×	42 0.4×	31	1.3k

Countries citing papers authored by Rosa Ayala

Since Specialization

Citations

This map shows the geographic impact of Rosa Ayala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Ayala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Ayala more than expected).

Fields of papers citing papers by Rosa Ayala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Ayala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Ayala. The network helps show where Rosa Ayala may publish in the future.

Co-authorship network of co-authors of Rosa Ayala

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Ayala. A scholar is included among the top collaborators of Rosa Ayala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Ayala. Rosa Ayala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliveira, Ana Carla, Tycho Baumann, Carlos Grande, et al.. (2025). Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma. Cancers. 17(7). 1065–1065.

Watts, Justin M., Alessandro M. Vannucchi, Anthony M. Hunter, et al.. (2024). Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 6576–6576. 1 indexed citations

Pemmaraju, Naveen, Tim C. P. Somervaille, Francesca Palandri, et al.. (2024). Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response. PubMed. 2(1). 100056–100056. 1 indexed citations

Castellano, Eva, Almudena García-Ortiz, Jessica Encinas, et al.. (2024). CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma. Blood. 144(Supplement 1). 3442–3442. 3 indexed citations

Ayala, Rosa, et al.. (2023). Impact of IPSS-M implementation in real-life clinical practice. Frontiers in Oncology. 13. 1199023–1199023. 3 indexed citations

Hernández‐Boluda, Juan Carlos, María Teresa Gómez‐Casares, Rosa Ayala, et al.. (2023). Efficacy of Consolidation Therapy with Ponatinib 15mg on Treatment-Free Remission Rate in Patients with Chronic Myeloid Leukemia. Results of the Ponazero Trial. Blood. 142(Supplement 1). 1795–1795. 1 indexed citations

Ayala, Rosa, Valentín García‐Gutiérrez, Alberto Álvarez‐Larrán, et al.. (2023). Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. SHILAP Revista de lepidopterología. 4(2). 401–409. 1 indexed citations

Morales, María Luz, José María Sánchez‐Pina, Rafael Alonso, et al.. (2023). Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical Cancer Research. 30(4). 904–917. 30 indexed citations

Barrio, Santiago, et al.. (2022). The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies. Cancers. 14(5). 1310–1310. 25 indexed citations

10.

Ayala, Rosa, Gema Hernández, Gonzalo Carreño‐Tarragona, et al.. (2022). Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network. Blood Cancer Journal. 12(6). 94–94. 5 indexed citations

11.

Ribera, Jordi, Isabel Granada, Mireia Morgades, et al.. (2021). Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols. British Journal of Haematology. 196(3). 670–675. 6 indexed citations

12.

Coloma, Javier Pardo de Santayana y, Bruna Calsina, María Monteagudo, et al.. (2020). Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma. Cancers. 12(11). 3304–3304. 9 indexed citations

13.

Sánchez, Ricardo, Jordi Ribera, Mireia Morgades, et al.. (2020). A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. Blood Cancer Journal. 10(4). 43–43. 12 indexed citations

14.

Ramos, Mónica, et al.. (2019). Aortic stenosis prognosis in older patients: frailty is a strong marker of early congestive heart failure admissions. European Geriatric Medicine. 10(3). 483–491. 5 indexed citations

15.

Osorio, Santiago, Pilar Giraldo, Beatriz Maestro, et al.. (2016). Leucemia mieloide crónica en España: sus características de presentación han cambiado. Sección española del registro poblacional EUTOS. Revista Clínica Española. 216(6). 293–300. 7 indexed citations

16.

Gallardo, Miguel, Santiago Barrio, Inmaculada Rapado, et al.. (2011). Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia. Annals of Hematology. 90(8). 939–946. 6 indexed citations

17.

Martínez‐Sánchez, Pilar, Laura Montejano, María Eugenia Sarasquete, et al.. (2008). Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response. British Journal of Haematology. 142(5). 766–774. 39 indexed citations

18.

Martínez‐López, Joaquín, Juan José Lahuerta, Pierre Salama, Rosa Ayala, & José M. Bautista. (2004). The use of fluorescent molecular beacons in real time PCR of IgH gene rearrangements for quantitative evaluation of multiple myeloma. Clinical & Laboratory Haematology. 26(1). 31–35. 5 indexed citations

19.

Ayala, Rosa, et al.. (1999). GIS Systems as Decision Support Tool for Agricultural Planning in Arid Zones of Spain. eCommons (Cornell University). 2 indexed citations

20.

Bienvenido, Fernando, Luís Iribarne, Rafael R. Sola‐Guirado, et al.. (1997). DAMOCIA-SIM, a generic tool for radation simulation into mild winter region greenhouses. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 287(14). 11338–50.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact